These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38874607)

  • 1. [Dermatomycoses: topical and systemic antifungal treatment].
    Nenoff P; Klonowski E; Uhrlaß S; Schaller M; Paasch U; Mayser P
    Dermatologie (Heidelb); 2024 Jun; ():. PubMed ID: 38874607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycology - an update Part 3: Dermatomycoses: topical and systemic therapy.
    Nenoff P; Krüger C; Paasch U; Ginter-Hanselmayer G
    J Dtsch Dermatol Ges; 2015 May; 13(5):387-410; quiz 411. PubMed ID: 25918080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extensive tinea corporis due to a terbinafine-resistant Trichophyton mentagrophytes isolate of the Indian genotype in a young infant from Bahrain in Germany].
    Süß A; Uhrlaß S; Ludes A; Verma SB; Monod M; Krüger C; Nenoff P
    Hautarzt; 2019 Nov; 70(11):888-896. PubMed ID: 31098692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes.
    Korting HC; Schöllmann C
    J Dtsch Dermatol Ges; 2009 Jan; 7(1):11-9, 11-20. PubMed ID: 18479501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
    Gupta AK; Einarson TR; Summerbell RC; Shear NH
    Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update in antifungal therapy of dermatophytosis.
    Gupta AK; Cooper EA
    Mycopathologia; 2008; 166(5-6):353-67. PubMed ID: 18478357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of Trichophyton indotineae: Implications for clinical practice.
    Gupta AK; Venkataraman M; Hall DC; Cooper EA; Summerbell RC
    Int J Dermatol; 2023 Jul; 62(7):857-861. PubMed ID: 35867962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Uhrlaß S; Verma SB; Gräser Y; Rezaei-Matehkolaei A; Hatami M; Schaller M; Nenoff P
    J Fungi (Basel); 2022 Jul; 8(7):. PubMed ID: 35887512
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermatophytes and skin dermatophytoses in Southeast Asia-First epidemiological survey from Cambodia.
    Uhrlaß S; Mey S; Koch D; Mütze H; Krüger C; Monod M; Nenoff P
    Mycoses; 2024 Apr; 67(4):e13718. PubMed ID: 38551112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?
    Sardana K; Kaur R; Arora P; Goyal R; Ghunawat S
    Indian Dermatol Online J; 2018; 9(2):90-95. PubMed ID: 29644192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antifungal agents in the treatment of superficial dermatomycoses].
    Degreef H
    Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent tinea corporis generalisata due to Terbinafine-resistant Trichophyton rubrum strain : Long-term treatment with super bioavailability itraconazole].
    Nenoff P; Stahl M; Schaller M; Burmester A; Monod M; Ebert A; Uhrlaß S
    Dermatologie (Heidelb); 2023 Nov; 74(11):864-873. PubMed ID: 37823916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral therapy of common superficial fungal infections of the skin.
    Lesher JL
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S31-4. PubMed ID: 10367914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.
    Gupta AK; Shear NH
    Drug Saf; 2000 Jan; 22(1):33-52. PubMed ID: 10647975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Antifungal Agents and New Formulations Against Dermatophytes.
    Gupta AK; Foley KA; Versteeg SG
    Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.